CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ProShare Advisors LLC 19,159$285,6610.00%
JPMORGAN CHASE & CO 362,687$5,407,6640.00%
US BANCORP \DE\ 45,057$671,8000.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 17,875$266,5160.00%
QUADRANT CAPITAL GROUP LLC 377$5,6220.00%
ALLIANCEBERNSTEIN L.P. 101,000$1,505,9100.00%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 99,436$1,482,5910.00%
GROUP ONE TRADING, L.P. 23,495$350,3100.00%
UBS Group AG 132,500$1,975,5750.00%
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM 27,990$417,3310.00%
Rafferty Asset Management, LLC 10,424$155,4220.00%
STRS OHIO 9,400$1400.00%
LPL Financial LLC 123,364$1,839,3570.00%
BNP PARIBAS FINANCIAL MARKETS 64,306$958,8020.00%
VOYA INVESTMENT MANAGEMENT LLC 39,705$592,0020.00%
MILLENNIUM MANAGEMENT LLC 143,404$2,138,1540.00%
Bank of New York Mellon Corp 375,549$5,599,4350.00%
Citadel Advisors 174,000$2,594,3400.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 193,300$2,882,1030.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 307,000$4,577,3700.00%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.